Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.419668802325305.
The log-likelihood improved by 3.78.
Iteration 2 of at most 500:
Optimizing with step length 0.646032188788462.
The log-likelihood improved by 2.579.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 3.537.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.8131.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       11     1167     1035      824      313      366      384 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     305      231      154       99       56       30       11        7 
degree16 degree18 
       5        1 
1 
disease_progression 
H-positive risk:  876 888 122 856 437 127 889 461 130 51 123 40 
H-negative risk:  888 876 889 856 461 437 127 122 123 130 40 51 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
55 new agents 
2 
disease_progression 
H-positive risk:  887 895 124 857 431 127 886 448 132 51 123 39 
H-negative risk:  895 887 886 857 448 431 127 124 123 132 39 51 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
69 new agents 
3 
disease_progression 
H-positive risk:  895 909 128 852 430 128 878 435 132 51 122 40 
H-negative risk:  909 895 878 852 435 430 128 128 122 132 40 51 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
70 new agents 
4 
disease_progression 
H-positive risk:  899 918 130 845 425 129 880 434 132 50 121 37 
H-negative risk:  918 899 880 845 434 425 129 130 121 132 37 50 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
56 new agents 
5 
disease_progression 
H-positive risk:  904 917 128 843 425 132 880 433 131 49 121 37 
H-negative risk:  917 904 880 843 433 425 132 128 121 131 37 49 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
60 new agents 
6 
disease_progression 
H-positive risk:  910 919 129 839 424 130 886 427 130 51 119 36 
H-negative risk:  919 910 886 839 427 424 130 129 119 130 36 51 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  920 920 131 838 420 129 884 418 131 51 120 38 
H-negative risk:  920 920 884 838 418 420 129 131 120 131 38 51 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 12 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
8 
disease_progression 
H-positive risk:  924 919 133 832 414 132 889 419 129 51 119 39 
H-negative risk:  919 924 889 832 419 414 132 133 119 129 39 51 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 14 3 

clinical_engagement 
diagnosis 
demography 
57 new agents 
9 
disease_progression 
H-positive risk:  924 927 134 831 412 134 883 411 132 51 121 40 
H-negative risk:  927 924 883 831 411 412 134 134 121 132 40 51 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 16 4 

clinical_engagement 
diagnosis 
demography 
41 new agents 
10 
disease_progression 
H-positive risk:  931 922 135 826 409 134 886 409 137 50 124 37 
H-negative risk:  922 931 886 826 409 409 134 135 124 137 37 50 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
61 new agents 
11 
disease_progression 
H-positive risk:  938 923 134 822 404 134 888 406 140 50 124 37 
H-negative risk:  923 938 888 822 406 404 134 134 124 140 37 50 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 17 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
12 
disease_progression 
H-positive risk:  942 923 133 819 400 138 893 400 141 51 124 36 
H-negative risk:  923 942 893 819 400 400 138 133 124 141 36 51 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 18 9 

clinical_engagement 
diagnosis 
demography 
56 new agents 
13 
disease_progression 
H-positive risk:  876 866 122 885 396 124 959 398 151 51 136 36 
H-negative risk:  866 876 959 885 398 396 124 122 136 151 36 51 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 18 9 

clinical_engagement 
diagnosis 
demography 
190 new agents 
14 
disease_progression 
H-positive risk:  904 887 125 845 401 130 923 416 139 55 128 47 
H-negative risk:  887 904 923 845 416 401 130 125 128 139 47 55 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 18 8 

clinical_engagement 
diagnosis 
demography 
53 new agents 
15 
disease_progression 
H-positive risk:  903 891 123 844 399 132 929 412 136 55 130 46 
H-negative risk:  891 903 929 844 412 399 132 123 130 136 46 55 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 20 8 

clinical_engagement 
diagnosis 
demography 
59 new agents 
16 
disease_progression 
H-positive risk:  903 890 125 851 395 131 929 411 135 54 129 47 
H-negative risk:  890 903 929 851 411 395 131 125 129 135 47 54 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
52 new agents 
17 
disease_progression 
H-positive risk:  904 897 126 849 396 133 920 411 134 54 130 46 
H-negative risk:  897 904 920 849 411 396 133 126 130 134 46 54 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 23 9 

clinical_engagement 
diagnosis 
demography 
66 new agents 
18 
disease_progression 
H-positive risk:  910 898 125 844 396 133 917 409 135 53 131 49 
H-negative risk:  898 910 917 844 409 396 133 125 131 135 49 53 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 24 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
19 
disease_progression 
H-positive risk:  915 905 126 837 390 134 916 408 136 52 131 50 
H-negative risk:  905 915 916 837 408 390 134 126 131 136 50 52 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 28 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
20 
disease_progression 
H-positive risk:  922 905 124 831 389 132 921 405 137 53 131 50 
H-negative risk:  905 922 921 831 405 389 132 124 131 137 50 53 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 28 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
21 
disease_progression 
H-positive risk:  923 911 127 836 384 132 923 393 136 54 129 52 
H-negative risk:  911 923 923 836 393 384 132 127 129 136 52 54 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 28 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
22 
disease_progression 
H-positive risk:  922 917 130 832 379 133 925 392 135 53 130 52 
H-negative risk:  917 922 925 832 392 379 133 130 130 135 52 53 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 28 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
23 
disease_progression 
H-positive risk:  920 916 131 834 373 135 937 387 134 53 128 52 
H-negative risk:  916 920 937 834 387 373 135 131 128 134 52 53 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 27 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
24 
disease_progression 
H-positive risk:  921 922 133 842 364 134 931 388 133 51 130 51 
H-negative risk:  922 921 931 842 388 364 134 133 130 133 51 51 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 30 27 

clinical_engagement 
diagnosis 
demography 
48 new agents 
25 
disease_progression 
H-positive risk:  856 848 121 917 366 131 994 385 139 50 141 52 
H-negative risk:  848 856 994 917 385 366 131 121 141 139 52 50 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 31 28 

clinical_engagement 
diagnosis 
demography 
193 new agents 
26 
disease_progression 
H-positive risk:  877 872 122 888 377 136 952 403 137 48 139 49 
H-negative risk:  872 877 952 888 403 377 136 122 139 137 49 48 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 35 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
27 
disease_progression 
H-positive risk:  881 880 122 886 377 133 946 402 136 48 140 49 
H-negative risk:  880 881 946 886 402 377 133 122 140 136 49 48 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 37 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
28 
disease_progression 
H-positive risk:  880 879 121 881 377 136 946 404 140 47 140 49 
H-negative risk:  879 880 946 881 404 377 136 121 140 140 49 47 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 39 27 

clinical_engagement 
diagnosis 
demography 
56 new agents 
29 
disease_progression 
H-positive risk:  880 880 121 890 377 136 944 400 139 46 139 48 
H-negative risk:  880 880 944 890 400 377 136 121 139 139 48 46 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 39 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
30 
disease_progression 
H-positive risk:  888 880 121 895 371 136 937 399 141 44 140 48 
H-negative risk:  880 888 937 895 399 371 136 121 140 141 48 44 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 43 29 

clinical_engagement 
diagnosis 
demography 
61 new agents 
31 
disease_progression 
H-positive risk:  895 888 122 893 358 139 935 398 143 44 139 46 
H-negative risk:  888 895 935 893 398 358 139 122 139 143 46 44 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 44 30 

clinical_engagement 
diagnosis 
demography 
60 new agents 
32 
disease_progression 
H-positive risk:  900 890 124 889 360 140 929 397 142 43 139 47 
H-negative risk:  890 900 929 889 397 360 140 124 139 142 47 43 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 45 30 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  894 895 125 897 361 139 924 394 141 43 139 48 
H-negative risk:  895 894 924 897 394 361 139 125 139 141 48 43 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 44 30 

clinical_engagement 
diagnosis 
demography 
53 new agents 
34 
disease_progression 
H-positive risk:  896 901 125 894 361 138 922 390 141 43 143 46 
H-negative risk:  901 896 922 894 390 361 138 125 143 141 46 43 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 45 30 

clinical_engagement 
diagnosis 
demography 
59 new agents 
35 
disease_progression 
H-positive risk:  898 905 125 894 355 140 923 387 142 43 143 45 
H-negative risk:  905 898 923 894 387 355 140 125 143 142 45 43 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 45 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
36 
disease_progression 
H-positive risk:  905 907 123 897 346 139 925 382 145 42 146 43 
H-negative risk:  907 905 925 897 382 346 139 123 146 145 43 42 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 48 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
37 
disease_progression 
H-positive risk:  837 841 114 968 345 130 991 383 154 43 152 42 
H-negative risk:  841 837 991 968 383 345 130 114 152 154 42 43 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 51 32 

clinical_engagement 
diagnosis 
demography 
164 new agents 
38 
disease_progression 
H-positive risk:  851 856 113 934 367 133 958 393 150 52 148 45 
H-negative risk:  856 851 958 934 393 367 133 113 148 150 45 52 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 53 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
39 
disease_progression 
H-positive risk:  853 857 115 932 362 134 965 388 148 53 146 47 
H-negative risk:  857 853 965 932 388 362 134 115 146 148 47 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 54 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
40 
disease_progression 
H-positive risk:  853 868 113 925 362 133 963 385 153 50 148 47 
H-negative risk:  868 853 963 925 385 362 133 113 148 153 47 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 55 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
41 
disease_progression 
H-positive risk:  854 875 113 915 362 135 964 384 154 50 148 46 
H-negative risk:  875 854 964 915 384 362 135 113 148 154 46 50 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 52 31 

clinical_engagement 
diagnosis 
demography 
61 new agents 
42 
disease_progression 
H-positive risk:  853 880 113 911 367 136 964 377 157 50 147 45 
H-negative risk:  880 853 964 911 377 367 136 113 147 157 45 50 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 50 31 

clinical_engagement 
diagnosis 
demography 
55 new agents 
43 
disease_progression 
H-positive risk:  855 881 111 911 365 139 964 376 156 48 149 45 
H-negative risk:  881 855 964 911 376 365 139 111 149 156 45 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 51 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
44 
disease_progression 
H-positive risk:  866 884 110 905 369 135 956 378 154 49 148 46 
H-negative risk:  884 866 956 905 378 369 135 110 148 154 46 49 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 54 32 

clinical_engagement 
diagnosis 
demography 
55 new agents 
45 
disease_progression 
H-positive risk:  874 886 111 906 364 135 952 381 149 47 149 46 
H-negative risk:  886 874 952 906 381 364 135 111 149 149 46 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 55 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
46 
disease_progression 
H-positive risk:  880 890 112 899 358 133 950 386 150 49 149 44 
H-negative risk:  890 880 950 899 386 358 133 112 149 150 44 49 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 55 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
47 
disease_progression 
H-positive risk:  881 898 113 892 357 132 946 386 152 50 149 44 
H-negative risk:  898 881 946 892 386 357 132 113 149 152 44 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 56 33 

clinical_engagement 
diagnosis 
demography 
60 new agents 
48 
disease_progression 
H-positive risk:  878 898 111 884 357 133 943 393 156 50 153 44 
H-negative risk:  898 878 943 884 393 357 133 111 153 156 44 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 57 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
49 
disease_progression 
H-positive risk:  823 849 100 942 356 117 1007 378 172 51 161 44 
H-negative risk:  849 823 1007 942 378 356 117 100 161 172 44 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 57 33 

clinical_engagement 
diagnosis 
demography 
125 new agents 
50 
disease_progression 
H-positive risk:  836 859 103 906 383 112 976 399 163 58 160 45 
H-negative risk:  859 836 976 906 399 383 112 103 160 163 45 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 58 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
51 
disease_progression 
H-positive risk:  838 860 101 909 384 111 968 396 167 60 161 45 
H-negative risk:  860 838 968 909 396 384 111 101 161 167 45 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 63 35 

clinical_engagement 
diagnosis 
demography 
69 new agents 
52 
disease_progression 
H-positive risk:  840 863 100 912 381 111 967 398 165 59 158 46 
H-negative risk:  863 840 967 912 398 381 111 100 158 165 46 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
53 
disease_progression 
H-positive risk:  840 872 101 902 374 111 974 397 164 59 161 45 
H-negative risk:  872 840 974 902 397 374 111 101 161 164 45 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 63 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
54 
disease_progression 
H-positive risk:  834 874 104 902 367 113 982 398 162 58 160 46 
H-negative risk:  874 834 982 902 398 367 113 104 160 162 46 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 64 33 

clinical_engagement 
diagnosis 
demography 
49 new agents 
55 
disease_progression 
H-positive risk:  829 871 105 897 372 110 992 399 162 58 159 46 
H-negative risk:  871 829 992 897 399 372 110 105 159 162 46 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 68 34 

clinical_engagement 
diagnosis 
demography 
46 new agents 
56 
disease_progression 
H-positive risk:  819 875 107 895 370 110 998 401 161 60 155 49 
H-negative risk:  875 819 998 895 401 370 110 107 155 161 49 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 71 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
57 
disease_progression 
H-positive risk:  821 878 107 891 365 109 1004 400 159 63 153 50 
H-negative risk:  878 821 1004 891 400 365 109 107 153 159 50 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
58 
disease_progression 
H-positive risk:  814 878 110 893 368 109 1013 394 161 63 150 47 
H-negative risk:  878 814 1013 893 394 368 109 110 150 161 47 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
54 new agents 
59 
disease_progression 
H-positive risk:  815 875 111 900 376 108 1009 391 159 61 150 45 
H-negative risk:  875 815 1009 900 391 376 108 111 150 159 45 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
60 
disease_progression 
H-positive risk:  823 884 114 902 366 108 1002 388 157 61 150 45 
H-negative risk:  884 823 1002 902 388 366 108 114 150 157 45 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
61 
disease_progression 
H-positive risk:  778 819 111 972 365 94 1054 377 169 60 154 47 
H-negative risk:  819 778 1054 972 377 365 94 111 154 169 47 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
127 new agents 
62 
disease_progression 
H-positive risk:  785 834 112 958 365 93 1035 398 165 59 148 48 
H-negative risk:  834 785 1035 958 398 365 93 112 148 165 48 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
56 new agents 
63 
disease_progression 
H-positive risk:  783 834 115 960 365 93 1026 403 165 60 144 52 
H-negative risk:  834 783 1026 960 403 365 93 115 144 165 52 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
64 
disease_progression 
H-positive risk:  786 828 115 965 362 94 1028 401 163 59 148 51 
H-negative risk:  828 786 1028 965 401 362 94 115 148 163 51 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
65 
disease_progression 
H-positive risk:  792 835 115 953 354 97 1033 398 166 61 148 48 
H-negative risk:  835 792 1033 953 398 354 97 115 148 166 48 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
57 new agents 
66 
disease_progression 
H-positive risk:  782 838 113 960 353 99 1033 398 166 60 150 48 
H-negative risk:  838 782 1033 960 398 353 99 113 150 166 48 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
67 
disease_progression 
H-positive risk:  785 838 112 967 350 99 1032 390 164 64 151 48 
H-negative risk:  838 785 1032 967 390 350 99 112 151 164 48 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
60 new agents 
68 
disease_progression 
H-positive risk:  786 837 113 976 346 99 1030 388 162 63 151 49 
H-negative risk:  837 786 1030 976 388 346 99 113 151 162 49 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
69 
disease_progression 
H-positive risk:  783 843 114 973 341 98 1033 390 164 62 152 47 
H-negative risk:  843 783 1033 973 390 341 98 114 152 164 47 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
70 
disease_progression 
H-positive risk:  789 838 111 975 345 99 1033 384 164 61 152 49 
H-negative risk:  838 789 1033 975 384 345 99 111 152 164 49 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
71 
disease_progression 
H-positive risk:  794 840 112 986 338 97 1028 380 163 58 154 50 
H-negative risk:  840 794 1028 986 380 338 97 112 154 163 50 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
72 
disease_progression 
H-positive risk:  796 841 112 987 331 98 1028 382 157 61 157 50 
H-negative risk:  841 796 1028 987 382 331 98 112 157 157 50 61 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
73 
disease_progression 
H-positive risk:  745 796 106 1042 328 90 1085 379 164 58 156 51 
H-negative risk:  796 745 1085 1042 379 328 90 106 156 164 51 58 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 92 31 

clinical_engagement 
diagnosis 
demography 
91 new agents 
74 
disease_progression 
H-positive risk:  746 789 104 1038 338 93 1067 391 163 60 152 59 
H-negative risk:  789 746 1067 1038 391 338 93 104 152 163 59 60 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
75 
disease_progression 
H-positive risk:  743 786 107 1038 342 96 1066 389 163 60 148 62 
H-negative risk:  786 743 1066 1038 389 342 96 107 148 163 62 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
76 
disease_progression 
H-positive risk:  746 782 108 1039 338 96 1072 381 167 62 148 61 
H-negative risk:  782 746 1072 1039 381 338 96 108 148 167 61 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
77 
disease_progression 
H-positive risk:  749 785 107 1037 331 98 1073 381 168 62 146 63 
H-negative risk:  785 749 1073 1037 381 331 98 107 146 168 63 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
78 
disease_progression 
H-positive risk:  743 788 106 1034 326 100 1080 383 169 60 147 64 
H-negative risk:  788 743 1080 1034 383 326 100 106 147 169 64 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  746 792 106 1031 319 98 1076 390 169 60 149 64 
H-negative risk:  792 746 1076 1031 390 319 98 106 149 169 64 60 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
80 
disease_progression 
H-positive risk:  749 789 106 1032 314 100 1075 396 169 60 146 64 
H-negative risk:  789 749 1075 1032 396 314 100 106 146 169 64 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 89 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
81 
disease_progression 
H-positive risk:  749 794 104 1039 314 98 1069 398 169 62 141 63 
H-negative risk:  794 749 1069 1039 398 314 98 104 141 169 63 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
82 
disease_progression 
H-positive risk:  745 794 105 1037 321 98 1081 391 168 61 140 59 
H-negative risk:  794 745 1081 1037 391 321 98 105 140 168 59 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
83 
disease_progression 
H-positive risk:  745 791 106 1046 318 100 1080 396 160 60 137 61 
H-negative risk:  791 745 1080 1046 396 318 100 106 137 160 61 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
47 new agents 
84 
disease_progression 
H-positive risk:  740 790 105 1049 313 100 1093 394 160 58 137 61 
H-negative risk:  790 740 1093 1049 394 313 100 105 137 160 61 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
85 
disease_progression 
H-positive risk:  691 744 95 1095 316 94 1145 397 162 58 146 57 
H-negative risk:  744 691 1145 1095 397 316 94 95 146 162 57 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
120 new agents 
86 
disease_progression 
H-positive risk:  694 756 97 1079 330 92 1122 406 162 58 147 57 
H-negative risk:  756 694 1122 1079 406 330 92 97 147 162 57 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
87 
disease_progression 
H-positive risk:  702 758 98 1075 336 95 1118 395 162 58 147 56 
H-negative risk:  758 702 1118 1075 395 336 95 98 147 162 56 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
88 
disease_progression 
H-positive risk:  699 760 99 1072 340 94 1120 395 163 56 146 56 
H-negative risk:  760 699 1120 1072 395 340 94 99 146 163 56 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
59 new agents 
89 
disease_progression 
H-positive risk:  699 753 102 1069 346 93 1120 397 164 55 146 56 
H-negative risk:  753 699 1120 1069 397 346 93 102 146 164 56 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
90 
disease_progression 
H-positive risk:  699 756 104 1069 347 94 1117 396 163 56 142 57 
H-negative risk:  756 699 1117 1069 396 347 94 104 142 163 57 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
91 
disease_progression 
H-positive risk:  694 760 103 1066 348 97 1116 393 163 60 142 58 
H-negative risk:  760 694 1116 1066 393 348 97 103 142 163 58 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
92 
disease_progression 
H-positive risk:  703 763 103 1068 341 97 1112 392 163 59 141 58 
H-negative risk:  763 703 1112 1068 392 341 97 103 141 163 58 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
93 
disease_progression 
H-positive risk:  704 759 101 1079 340 99 1107 395 163 55 143 55 
H-negative risk:  759 704 1107 1079 395 340 99 101 143 163 55 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
94 
disease_progression 
H-positive risk:  707 755 100 1091 340 99 1106 388 158 56 144 56 
H-negative risk:  755 707 1106 1091 388 340 99 100 144 158 56 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
95 
disease_progression 
H-positive risk:  710 745 100 1092 338 99 1114 391 157 55 142 57 
H-negative risk:  745 710 1114 1092 391 338 99 100 142 157 57 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
96 
disease_progression 
H-positive risk:  712 750 101 1095 329 100 1111 391 157 56 142 56 
H-negative risk:  750 712 1111 1095 391 329 100 101 142 157 56 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
97 
disease_progression 
H-positive risk:  679 707 99 1141 324 94 1144 395 158 55 143 61 
H-negative risk:  707 679 1144 1141 395 324 94 99 143 158 61 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
90 new agents 
98 
disease_progression 
H-positive risk:  671 704 98 1134 339 95 1134 408 154 55 147 61 
H-negative risk:  704 671 1134 1134 408 339 95 98 147 154 61 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
99 
disease_progression 
H-positive risk:  669 706 99 1138 339 95 1131 406 150 57 148 62 
H-negative risk:  706 669 1131 1138 406 339 95 99 148 150 62 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
100 
disease_progression 
H-positive risk:  675 705 100 1137 339 98 1126 401 150 57 148 64 
H-negative risk:  705 675 1126 1137 401 339 98 100 148 150 64 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
101 
disease_progression 
H-positive risk:  675 697 100 1136 338 99 1143 395 150 57 149 61 
H-negative risk:  697 675 1143 1136 395 338 99 100 149 150 61 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
102 
disease_progression 
H-positive risk:  685 707 100 1133 343 97 1137 391 148 57 142 60 
H-negative risk:  707 685 1137 1133 391 343 97 100 142 148 60 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
103 
disease_progression 
H-positive risk:  680 696 100 1134 351 98 1138 396 147 58 142 60 
H-negative risk:  696 680 1138 1134 396 351 98 100 142 147 60 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
91 new agents 
104 
disease_progression 
H-positive risk:  687 696 104 1133 351 99 1138 389 145 60 142 56 
H-negative risk:  696 687 1138 1133 389 351 99 104 142 145 56 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
105 
disease_progression 
H-positive risk:  682 696 103 1132 351 100 1148 387 147 59 139 56 
H-negative risk:  696 682 1148 1132 387 351 100 103 139 147 56 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
106 
disease_progression 
H-positive risk:  683 702 101 1133 354 99 1147 379 148 58 142 54 
H-negative risk:  702 683 1147 1133 379 354 99 101 142 148 54 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
65 new agents 
107 
disease_progression 
H-positive risk:  682 706 104 1132 353 97 1146 382 150 55 139 54 
H-negative risk:  706 682 1146 1132 382 353 97 104 139 150 54 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
108 
disease_progression 
H-positive risk:  679 709 104 1128 352 96 1146 395 150 53 138 50 
H-negative risk:  709 679 1146 1128 395 352 96 104 138 150 50 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
109 
disease_progression 
H-positive risk:  649 668 100 1163 354 91 1178 398 152 52 144 51 
H-negative risk:  668 649 1178 1163 398 354 91 100 144 152 51 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 76 37 

clinical_engagement 
diagnosis 
demography 
88 new agents 
110 
disease_progression 
H-positive risk:  654 663 97 1163 356 93 1154 420 148 55 143 54 
H-negative risk:  663 654 1154 1163 420 356 93 97 143 148 54 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 76 36 

clinical_engagement 
diagnosis 
demography 
95 new agents 
111 
disease_progression 
H-positive risk:  656 665 98 1169 352 92 1155 419 146 52 145 51 
H-negative risk:  665 656 1155 1169 419 352 92 98 145 146 51 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 76 35 

clinical_engagement 
diagnosis 
demography 
84 new agents 
112 
disease_progression 
H-positive risk:  652 666 101 1163 353 95 1164 419 147 51 141 48 
H-negative risk:  666 652 1164 1163 419 353 95 101 141 147 48 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
66 new agents 
113 
disease_progression 
H-positive risk:  644 664 103 1158 354 96 1168 424 146 55 140 48 
H-negative risk:  664 644 1168 1158 424 354 96 103 140 146 48 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
114 
disease_progression 
H-positive risk:  644 660 103 1154 361 95 1166 423 145 56 142 51 
H-negative risk:  660 644 1166 1154 423 361 95 103 142 145 51 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
73 new agents 
115 
disease_progression 
H-positive risk:  647 665 102 1143 363 96 1173 420 146 56 140 49 
H-negative risk:  665 647 1173 1143 420 363 96 102 140 146 49 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
92 new agents 
116 
disease_progression 
H-positive risk:  652 664 101 1137 366 97 1176 419 141 58 141 48 
H-negative risk:  664 652 1176 1137 419 366 97 101 141 141 48 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
117 
disease_progression 
H-positive risk:  660 669 102 1134 367 96 1175 412 140 55 141 49 
H-negative risk:  669 660 1175 1134 412 367 96 102 141 140 49 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 81 34 

clinical_engagement 
diagnosis 
demography 
64 new agents 
118 
disease_progression 
H-positive risk:  655 668 102 1130 376 96 1177 410 142 55 140 49 
H-negative risk:  668 655 1177 1130 410 376 96 102 140 142 49 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 82 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
119 
disease_progression 
H-positive risk:  655 672 101 1132 374 95 1167 413 147 55 139 50 
H-negative risk:  672 655 1167 1132 413 374 95 101 139 147 50 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
61 new agents 
120 
disease_progression 
H-positive risk:  653 668 100 1132 373 95 1175 414 149 52 138 51 
H-negative risk:  668 653 1175 1132 414 373 95 100 138 149 51 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 82 36 

clinical_engagement 
diagnosis 
demography 
62 new agents 
121 
disease_progression 
H-positive risk:  611 625 95 1178 373 89 1212 413 154 54 144 52 
H-negative risk:  625 611 1212 1178 413 373 89 95 144 154 52 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
73 new agents 
122 
disease_progression 
H-positive risk:  601 624 94 1156 395 89 1210 422 159 54 145 51 
H-negative risk:  624 601 1210 1156 422 395 89 94 145 159 51 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 81 37 

clinical_engagement 
diagnosis 
demography 
78 new agents 
123 
disease_progression 
H-positive risk:  599 633 91 1147 408 88 1201 424 158 56 144 51 
H-negative risk:  633 599 1201 1147 424 408 88 91 144 158 51 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
80 new agents 
124 
disease_progression 
H-positive risk:  610 643 91 1133 413 88 1196 422 157 55 142 50 
H-negative risk:  643 610 1196 1133 422 413 88 91 142 157 50 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
90 new agents 
125 
disease_progression 
H-positive risk:  617 643 88 1140 407 88 1186 424 154 57 143 53 
H-negative risk:  643 617 1186 1140 424 407 88 88 143 154 53 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 76 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
126 
disease_progression 
H-positive risk:  619 647 88 1143 407 85 1177 426 154 56 143 55 
H-negative risk:  647 619 1177 1143 426 407 85 88 143 154 55 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 75 39 

clinical_engagement 
diagnosis 
demography 
67 new agents 
127 
disease_progression 
H-positive risk:  622 646 89 1143 407 86 1181 417 156 56 142 55 
H-negative risk:  646 622 1181 1143 417 407 86 89 142 156 55 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 80 39 

clinical_engagement 
diagnosis 
demography 
90 new agents 
128 
disease_progression 
H-positive risk:  625 656 87 1145 405 85 1175 406 161 56 141 58 
H-negative risk:  656 625 1175 1145 406 405 85 87 141 161 58 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 82 38 

clinical_engagement 
diagnosis 
demography 
80 new agents 
129 
disease_progression 
H-positive risk:  625 650 87 1144 409 84 1186 401 163 56 141 54 
H-negative risk:  650 625 1186 1144 401 409 84 87 141 163 54 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 82 38 

clinical_engagement 
diagnosis 
demography 
68 new agents 
130 
disease_progression 
H-positive risk:  631 646 87 1135 408 85 1191 401 160 58 143 55 
H-negative risk:  646 631 1191 1135 401 408 85 87 143 160 55 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 81 38 

clinical_engagement 
diagnosis 
demography 
85 new agents 
131 
disease_progression 
H-positive risk:  637 644 89 1141 411 85 1186 393 158 58 143 55 
H-negative risk:  644 637 1186 1141 393 411 85 89 143 158 55 58 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 80 40 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  634 645 89 1147 413 89 1185 389 154 57 144 54 
H-negative risk:  645 634 1185 1147 389 413 89 89 144 154 54 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 78 39 

clinical_engagement 
diagnosis 
demography 
67 new agents 
133 
disease_progression 
H-positive risk:  636 638 88 1151 409 89 1188 388 152 60 145 56 
H-negative risk:  638 636 1188 1151 388 409 89 88 145 152 56 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 78 36 

clinical_engagement 
diagnosis 
demography 
98 new agents 
134 
disease_progression 
H-positive risk:  644 642 89 1147 410 86 1180 387 155 57 144 59 
H-negative risk:  642 644 1180 1147 387 410 86 89 144 155 59 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
77 new agents 
135 
disease_progression 
H-positive risk:  652 635 87 1152 414 87 1167 394 153 58 143 58 
H-negative risk:  635 652 1167 1152 394 414 87 87 143 153 58 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 73 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
136 
disease_progression 
H-positive risk:  657 633 86 1158 412 90 1170 388 148 56 141 61 
H-negative risk:  633 657 1170 1158 388 412 90 86 141 148 61 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 73 37 

clinical_engagement 
diagnosis 
demography 
64 new agents 
137 
disease_progression 
H-positive risk:  651 634 85 1170 408 91 1167 392 144 55 141 62 
H-negative risk:  634 651 1167 1170 392 408 91 85 141 144 62 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
77 new agents 
138 
disease_progression 
H-positive risk:  656 637 82 1164 406 92 1160 402 142 55 142 62 
H-negative risk:  637 656 1160 1164 402 406 92 82 142 142 62 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
74 new agents 
139 
disease_progression 
H-positive risk:  657 639 82 1162 404 91 1158 401 146 57 144 59 
H-negative risk:  639 657 1158 1162 401 404 91 82 144 146 59 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
80 new agents 
140 
disease_progression 
H-positive risk:  651 630 84 1164 410 90 1176 395 144 55 143 58 
H-negative risk:  630 651 1176 1164 395 410 90 84 143 144 58 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
90 new agents 
141 
disease_progression 
H-positive risk:  659 627 86 1157 423 91 1167 395 145 53 142 55 
H-negative risk:  627 659 1167 1157 395 423 91 86 142 145 55 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 78 36 

clinical_engagement 
diagnosis 
demography 
56 new agents 
142 
disease_progression 
H-positive risk:  660 625 86 1155 420 93 1160 405 144 51 145 56 
H-negative risk:  625 660 1160 1155 405 420 93 86 145 144 56 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
72 new agents 
143 
disease_progression 
H-positive risk:  662 632 84 1158 417 93 1153 399 148 52 148 54 
H-negative risk:  632 662 1153 1158 399 417 93 84 148 148 54 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
144 
disease_progression 
H-positive risk:  663 636 88 1151 419 95 1157 392 148 48 148 55 
H-negative risk:  636 663 1157 1151 392 419 95 88 148 148 55 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
145 
disease_progression 
H-positive risk:  666 640 88 1150 417 97 1160 394 145 45 147 51 
H-negative risk:  640 666 1160 1150 394 417 97 88 147 145 51 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
146 
disease_progression 
H-positive risk:  660 640 90 1153 425 100 1140 404 138 52 146 52 
H-negative risk:  640 660 1140 1153 404 425 100 90 146 138 52 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
147 
disease_progression 
H-positive risk:  660 638 95 1147 430 99 1143 399 137 55 146 51 
H-negative risk:  638 660 1143 1147 399 430 99 95 146 137 51 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
148 
disease_progression 
H-positive risk:  660 639 93 1150 428 102 1138 406 134 54 144 52 
H-negative risk:  639 660 1138 1150 406 428 102 93 144 134 52 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
149 
disease_progression 
H-positive risk:  653 637 93 1153 428 100 1135 413 136 54 145 53 
H-negative risk:  637 653 1135 1153 413 428 100 93 145 136 53 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
150 
disease_progression 
H-positive risk:  656 636 90 1154 428 103 1134 413 137 51 148 50 
H-negative risk:  636 656 1134 1154 413 428 103 90 148 137 50 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
151 
disease_progression 
H-positive risk:  660 639 90 1151 424 106 1136 414 133 51 148 48 
H-negative risk:  639 660 1136 1151 414 424 106 90 148 133 48 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
152 
disease_progression 
H-positive risk:  660 638 93 1144 426 103 1152 405 136 48 146 49 
H-negative risk:  638 660 1152 1144 405 426 103 93 146 136 49 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
153 
disease_progression 
H-positive risk:  672 634 93 1148 422 102 1148 402 139 45 145 50 
H-negative risk:  634 672 1148 1148 402 422 102 93 145 139 50 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
154 
disease_progression 
H-positive risk:  672 635 92 1136 422 104 1155 406 140 47 142 49 
H-negative risk:  635 672 1155 1136 406 422 104 92 142 140 49 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
155 
disease_progression 
H-positive risk:  674 632 94 1131 423 105 1152 409 141 47 142 50 
H-negative risk:  632 674 1152 1131 409 423 105 94 142 141 50 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
156 
disease_progression 
H-positive risk:  679 637 94 1129 426 104 1155 398 138 48 142 50 
H-negative risk:  637 679 1155 1129 398 426 104 94 142 138 50 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
157 
disease_progression 
H-positive risk:  672 629 94 1133 421 107 1162 402 140 46 142 52 
H-negative risk:  629 672 1162 1133 402 421 107 94 142 140 52 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
158 
disease_progression 
H-positive risk:  668 621 97 1119 435 107 1162 410 139 45 144 53 
H-negative risk:  621 668 1162 1119 410 435 107 97 144 139 53 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
159 
disease_progression 
H-positive risk:  674 628 97 1108 437 105 1162 411 141 44 143 50 
H-negative risk:  628 674 1162 1108 411 437 105 97 143 141 50 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
160 
disease_progression 
H-positive risk:  674 619 96 1114 437 106 1160 420 140 45 138 51 
H-negative risk:  619 674 1160 1114 420 437 106 96 138 140 51 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
161 
disease_progression 
H-positive risk:  676 627 96 1113 437 106 1158 410 142 44 139 52 
H-negative risk:  627 676 1158 1113 410 437 106 96 139 142 52 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
162 
disease_progression 
H-positive risk:  674 636 94 1111 435 105 1157 405 142 45 145 51 
H-negative risk:  636 674 1157 1111 405 435 105 94 145 142 51 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
163 
disease_progression 
H-positive risk:  670 636 95 1103 449 103 1156 404 143 46 146 49 
H-negative risk:  636 670 1156 1103 404 449 103 95 146 143 49 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
164 
disease_progression 
H-positive risk:  668 638 95 1099 450 103 1156 402 142 47 149 51 
H-negative risk:  638 668 1156 1099 402 450 103 95 149 142 51 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
165 
disease_progression 
H-positive risk:  667 633 94 1110 446 104 1158 402 138 47 148 53 
H-negative risk:  633 667 1158 1110 402 446 104 94 148 138 53 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
166 
disease_progression 
H-positive risk:  675 630 94 1111 441 104 1152 407 140 48 146 52 
H-negative risk:  630 675 1152 1111 407 441 104 94 146 140 52 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
167 
disease_progression 
H-positive risk:  678 633 90 1113 436 105 1156 403 138 47 148 53 
H-negative risk:  633 678 1156 1113 403 436 105 90 148 138 53 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
61 new agents 
168 
disease_progression 
H-positive risk:  675 633 91 1110 434 108 1160 404 138 47 148 52 
H-negative risk:  633 675 1160 1110 404 434 108 91 148 138 52 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 82 37 

clinical_engagement 
diagnosis 
demography 
73 new agents 
169 
disease_progression 
H-positive risk:  662 640 92 1105 431 108 1164 406 144 48 148 52 
H-negative risk:  640 662 1164 1105 406 431 108 92 148 144 52 48 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
84 new agents 
170 
disease_progression 
H-positive risk:  662 642 91 1098 437 107 1155 420 146 49 142 51 
H-negative risk:  642 662 1155 1098 420 437 107 91 142 146 51 49 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 82 37 

clinical_engagement 
diagnosis 
demography 
79 new agents 
171 
disease_progression 
H-positive risk:  658 638 92 1100 439 106 1156 416 150 49 145 51 
H-negative risk:  638 658 1156 1100 416 439 106 92 145 150 51 49 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
71 new agents 
172 
disease_progression 
H-positive risk:  660 643 92 1093 443 101 1162 411 152 50 141 52 
H-negative risk:  643 660 1162 1093 411 443 101 92 141 152 52 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
173 
disease_progression 
H-positive risk:  662 639 92 1098 442 100 1156 416 155 50 137 53 
H-negative risk:  639 662 1156 1098 416 442 100 92 137 155 53 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 84 37 

clinical_engagement 
diagnosis 
demography 
92 new agents 
174 
disease_progression 
H-positive risk:  663 643 90 1104 444 100 1148 416 155 49 138 50 
H-negative risk:  643 663 1148 1104 416 444 100 90 138 155 50 49 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 85 37 

clinical_engagement 
diagnosis 
demography 
80 new agents 
175 
disease_progression 
H-positive risk:  664 640 92 1107 435 98 1141 427 155 50 141 50 
H-negative risk:  640 664 1141 1107 427 435 98 92 141 155 50 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 86 37 

clinical_engagement 
diagnosis 
demography 
72 new agents 
176 
disease_progression 
H-positive risk:  671 635 92 1104 436 100 1135 426 153 54 145 49 
H-negative risk:  635 671 1135 1104 426 436 100 92 145 153 49 54 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 87 38 

clinical_engagement 
diagnosis 
demography 
75 new agents 
177 
disease_progression 
H-positive risk:  662 626 94 1106 438 99 1143 430 157 52 145 48 
H-negative risk:  626 662 1143 1106 430 438 99 94 145 157 48 52 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 85 38 

clinical_engagement 
diagnosis 
demography 
89 new agents 
178 
disease_progression 
H-positive risk:  662 624 94 1111 443 97 1135 432 161 55 141 45 
H-negative risk:  624 662 1135 1111 432 443 97 94 141 161 45 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 83 38 

clinical_engagement 
diagnosis 
demography 
63 new agents 
179 
disease_progression 
H-positive risk:  667 618 92 1122 446 100 1121 429 159 56 143 47 
H-negative risk:  618 667 1121 1122 429 446 100 92 143 159 47 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
71 new agents 
180 
disease_progression 
H-positive risk:  664 613 90 1127 450 97 1121 428 158 60 145 47 
H-negative risk:  613 664 1121 1127 428 450 97 90 145 158 47 60 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 86 35 

clinical_engagement 
diagnosis 
demography 
64 new agents 
181 
disease_progression 
H-positive risk:  661 612 92 1125 446 97 1125 433 154 62 147 46 
H-negative risk:  612 661 1125 1125 433 446 97 92 147 154 46 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 86 34 

clinical_engagement 
diagnosis 
demography 
85 new agents 
182 
disease_progression 
H-positive risk:  657 629 92 1119 444 96 1108 446 151 63 148 47 
H-negative risk:  629 657 1108 1119 446 444 96 92 148 151 47 63 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 87 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
183 
disease_progression 
H-positive risk:  656 628 94 1114 447 97 1104 449 151 62 152 46 
H-negative risk:  628 656 1104 1114 449 447 97 94 152 151 46 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 84 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
184 
disease_progression 
H-positive risk:  662 634 93 1114 435 96 1109 445 152 59 154 47 
H-negative risk:  634 662 1109 1114 445 435 96 93 154 152 47 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
185 
disease_progression 
H-positive risk:  668 643 91 1123 425 97 1106 443 151 58 152 43 
H-negative risk:  643 668 1106 1123 443 425 97 91 152 151 43 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 89 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
186 
disease_progression 
H-positive risk:  663 640 92 1128 425 98 1105 443 150 61 151 44 
H-negative risk:  640 663 1105 1128 443 425 98 92 151 150 44 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 90 35 

clinical_engagement 
diagnosis 
demography 
89 new agents 
187 
disease_progression 
H-positive risk:  671 642 92 1120 431 99 1100 442 148 58 155 42 
H-negative risk:  642 671 1100 1120 442 431 99 92 155 148 42 58 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 88 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  678 644 91 1117 431 100 1093 445 146 60 153 42 
H-negative risk:  644 678 1093 1117 445 431 100 91 153 146 42 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
189 
disease_progression 
H-positive risk:  679 645 86 1119 437 101 1084 442 147 60 154 46 
H-negative risk:  645 679 1084 1119 442 437 101 86 154 147 46 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
190 
disease_progression 
H-positive risk:  678 640 88 1132 429 103 1084 445 148 53 154 46 
H-negative risk:  640 678 1084 1132 445 429 103 88 154 148 46 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
191 
disease_progression 
H-positive risk:  681 641 88 1125 429 104 1083 444 147 57 155 46 
H-negative risk:  641 681 1083 1125 444 429 104 88 155 147 46 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
192 
disease_progression 
H-positive risk:  682 646 88 1129 422 105 1083 442 151 53 155 44 
H-negative risk:  646 682 1083 1129 442 422 105 88 155 151 44 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
193 
disease_progression 
H-positive risk:  682 656 88 1109 429 104 1081 448 151 53 154 45 
H-negative risk:  656 682 1081 1109 448 429 104 88 154 151 45 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
89 new agents 
194 
disease_progression 
H-positive risk:  680 652 89 1103 434 106 1075 458 147 57 149 50 
H-negative risk:  652 680 1075 1103 458 434 106 89 149 147 50 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 85 37 

clinical_engagement 
diagnosis 
demography 
75 new agents 
195 
disease_progression 
H-positive risk:  684 645 90 1105 437 105 1079 452 148 56 148 51 
H-negative risk:  645 684 1079 1105 452 437 105 90 148 148 51 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 87 38 

clinical_engagement 
diagnosis 
demography 
84 new agents 
196 
disease_progression 
H-positive risk:  688 650 91 1098 443 105 1074 452 144 56 151 48 
H-negative risk:  650 688 1074 1098 452 443 105 91 151 144 48 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 87 37 

clinical_engagement 
diagnosis 
demography 
103 new agents 
197 
disease_progression 
H-positive risk:  694 660 91 1098 447 106 1061 448 141 56 146 52 
H-negative risk:  660 694 1061 1098 448 447 106 91 146 141 52 56 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
198 
disease_progression 
H-positive risk:  685 663 90 1088 461 106 1063 449 143 56 146 50 
H-negative risk:  663 685 1063 1088 449 461 106 90 146 143 50 56 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
85 new agents 
199 
disease_progression 
H-positive risk:  692 659 91 1085 460 107 1071 445 142 56 142 50 
H-negative risk:  659 692 1071 1085 445 460 107 91 142 142 50 56 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 92 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
200 
disease_progression 
H-positive risk:  696 657 88 1085 458 105 1069 450 144 58 137 53 
H-negative risk:  657 696 1069 1085 450 458 105 88 137 144 53 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 92 34 

clinical_engagement 
diagnosis 
demography 
86 new agents 
201 
disease_progression 
H-positive risk:  694 660 90 1089 456 106 1064 453 144 55 138 51 
H-negative risk:  660 694 1064 1089 453 456 106 90 138 144 51 55 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
202 
disease_progression 
H-positive risk:  700 660 92 1093 461 104 1056 448 143 55 135 53 
H-negative risk:  660 700 1056 1093 448 461 104 92 135 143 53 55 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
60 new agents 
203 
disease_progression 
H-positive risk:  691 654 91 1090 456 104 1068 455 146 56 135 54 
H-negative risk:  654 691 1068 1090 455 456 104 91 135 146 54 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
63 new agents 
204 
disease_progression 
H-positive risk:  685 658 90 1088 461 105 1071 448 147 55 137 55 
H-negative risk:  658 685 1071 1088 448 461 105 90 137 147 55 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 91 33 

clinical_engagement 
diagnosis 
demography 
61 new agents 
205 
disease_progression 
H-positive risk:  684 655 89 1086 464 104 1071 446 148 57 138 58 
H-negative risk:  655 684 1071 1086 446 464 104 89 138 148 58 57 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 90 33 

clinical_engagement 
diagnosis 
demography 
97 new agents 
206 
disease_progression 
H-positive risk:  684 658 91 1079 467 105 1057 461 145 58 139 56 
H-negative risk:  658 684 1057 1079 461 467 105 91 139 145 56 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
207 
disease_progression 
H-positive risk:  682 655 92 1083 458 106 1060 462 142 59 143 58 
H-negative risk:  655 682 1060 1083 462 458 106 92 143 142 58 59 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
208 
disease_progression 
H-positive risk:  682 656 94 1085 454 108 1063 461 138 58 144 57 
H-negative risk:  656 682 1063 1085 461 454 108 94 144 138 57 58 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
209 
disease_progression 
H-positive risk:  675 659 94 1094 453 107 1059 458 141 59 145 56 
H-negative risk:  659 675 1059 1094 458 453 107 94 145 141 56 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
210 
disease_progression 
H-positive risk:  683 656 95 1102 451 107 1044 459 141 60 145 57 
H-negative risk:  656 683 1044 1102 459 451 107 95 145 141 57 60 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 94 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
211 
disease_progression 
H-positive risk:  682 663 94 1095 444 104 1057 455 148 58 146 54 
H-negative risk:  663 682 1057 1095 455 444 104 94 146 148 54 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 93 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
212 
disease_progression 
H-positive risk:  685 670 94 1091 445 105 1052 452 148 58 148 52 
H-negative risk:  670 685 1052 1091 452 445 105 94 148 148 52 58 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 91 37 

clinical_engagement 
diagnosis 
demography 
91 new agents 
213 
disease_progression 
H-positive risk:  681 676 96 1099 443 106 1044 458 145 58 140 54 
H-negative risk:  676 681 1044 1099 458 443 106 96 140 145 54 58 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 88 37 

clinical_engagement 
diagnosis 
demography 
77 new agents 
214 
disease_progression 
H-positive risk:  680 676 96 1102 440 106 1049 451 143 60 142 55 
H-negative risk:  676 680 1049 1102 451 440 106 96 142 143 55 60 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 88 37 

clinical_engagement 
diagnosis 
demography 
67 new agents 
215 
disease_progression 
H-positive risk:  682 680 98 1106 437 107 1046 449 145 60 140 50 
H-negative risk:  680 682 1046 1106 449 437 107 98 140 145 50 60 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 87 38 

clinical_engagement 
diagnosis 
demography 
64 new agents 
216 
disease_progression 
H-positive risk:  674 688 97 1101 439 107 1048 450 146 61 139 50 
H-negative risk:  688 674 1048 1101 450 439 107 97 139 146 50 61 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 86 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
217 
disease_progression 
H-positive risk:  672 697 96 1091 446 105 1048 452 144 59 138 52 
H-negative risk:  697 672 1048 1091 452 446 105 96 138 144 52 59 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 89 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
218 
disease_progression 
H-positive risk:  674 695 96 1096 441 104 1053 451 147 56 137 50 
H-negative risk:  695 674 1053 1096 451 441 104 96 137 147 50 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 89 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
219 
disease_progression 
H-positive risk:  669 688 95 1097 441 102 1066 454 148 53 135 52 
H-negative risk:  688 669 1066 1097 454 441 102 95 135 148 52 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 87 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
220 
disease_progression 
H-positive risk:  673 695 92 1094 438 100 1061 456 150 54 136 51 
H-negative risk:  695 673 1061 1094 456 438 100 92 136 150 51 54 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 91 34 

clinical_engagement 
diagnosis 
demography 
76 new agents 
221 
disease_progression 
H-positive risk:  672 698 94 1085 441 102 1057 459 150 54 137 51 
H-negative risk:  698 672 1057 1085 459 441 102 94 137 150 51 54 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
222 
disease_progression 
H-positive risk:  670 703 94 1088 439 102 1054 458 149 56 138 49 
H-negative risk:  703 670 1054 1088 458 439 102 94 138 149 49 56 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 89 32 

clinical_engagement 
diagnosis 
demography 
88 new agents 
223 
disease_progression 
H-positive risk:  670 704 94 1094 434 103 1056 450 153 55 134 53 
H-negative risk:  704 670 1056 1094 450 434 103 94 134 153 53 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
224 
disease_progression 
H-positive risk:  668 702 93 1094 427 105 1071 440 156 56 135 53 
H-negative risk:  702 668 1071 1094 440 427 105 93 135 156 53 56 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
225 
disease_progression 
H-positive risk:  661 711 94 1093 432 106 1060 441 156 57 136 53 
H-negative risk:  711 661 1060 1093 441 432 106 94 136 156 53 57 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 92 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
226 
disease_progression 
H-positive risk:  663 714 97 1086 434 105 1066 432 158 55 135 55 
H-negative risk:  714 663 1066 1086 432 434 105 97 135 158 55 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
227 
disease_progression 
H-positive risk:  664 718 97 1090 435 104 1057 435 159 52 135 54 
H-negative risk:  718 664 1057 1090 435 435 104 97 135 159 54 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
228 
disease_progression 
H-positive risk:  671 722 98 1087 433 103 1057 428 160 51 135 55 
H-negative risk:  722 671 1057 1087 428 433 103 98 135 160 55 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
229 
disease_progression 
H-positive risk:  666 724 98 1081 435 101 1056 438 158 52 136 55 
H-negative risk:  724 666 1056 1081 438 435 101 98 136 158 55 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
230 
disease_progression 
H-positive risk:  671 719 95 1087 436 100 1055 435 159 51 137 55 
H-negative risk:  719 671 1055 1087 435 436 100 95 137 159 55 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 85 35 

clinical_engagement 
diagnosis 
demography 
89 new agents 
231 
disease_progression 
H-positive risk:  676 732 93 1068 443 103 1047 435 158 53 138 54 
H-negative risk:  732 676 1047 1068 435 443 103 93 138 158 54 53 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
90 new agents 
232 
disease_progression 
H-positive risk:  675 733 93 1070 446 105 1040 438 156 54 137 53 
H-negative risk:  733 675 1040 1070 438 446 105 93 137 156 53 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
67 new agents 
233 
disease_progression 
H-positive risk:  686 730 94 1066 443 101 1043 435 156 56 138 52 
H-negative risk:  730 686 1043 1066 435 443 101 94 138 156 52 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
234 
disease_progression 
H-positive risk:  691 728 93 1061 446 98 1048 434 154 56 136 55 
H-negative risk:  728 691 1048 1061 434 446 98 93 136 154 55 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
235 
disease_progression 
H-positive risk:  691 725 94 1068 445 97 1048 431 152 54 136 59 
H-negative risk:  725 691 1048 1068 431 445 97 94 136 152 59 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
236 
disease_progression 
H-positive risk:  695 725 95 1061 450 99 1048 429 150 54 136 58 
H-negative risk:  725 695 1048 1061 429 450 99 95 136 150 58 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
237 
disease_progression 
H-positive risk:  700 725 96 1061 449 94 1047 432 154 52 133 57 
H-negative risk:  725 700 1047 1061 432 449 94 96 133 154 57 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
238 
disease_progression 
H-positive risk:  702 724 98 1063 438 99 1046 439 151 52 130 58 
H-negative risk:  724 702 1046 1063 439 438 99 98 130 151 58 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
239 
disease_progression 
H-positive risk:  704 724 101 1066 437 101 1038 433 152 55 129 60 
H-negative risk:  724 704 1038 1066 433 437 101 101 129 152 60 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
240 
disease_progression 
H-positive risk:  702 719 99 1072 444 101 1037 434 150 54 129 59 
H-negative risk:  719 702 1037 1072 434 444 101 99 129 150 59 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
241 
disease_progression 
H-positive risk:  701 704 101 1065 455 103 1031 445 149 58 130 58 
H-negative risk:  704 701 1031 1065 445 455 103 101 130 149 58 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
104 new agents 
242 
disease_progression 
H-positive risk:  707 709 100 1077 448 102 1023 443 147 56 127 61 
H-negative risk:  709 707 1023 1077 443 448 102 100 127 147 61 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
243 
disease_progression 
H-positive risk:  709 712 99 1070 442 106 1030 435 148 56 129 64 
H-negative risk:  712 709 1030 1070 435 442 106 99 129 148 64 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
244 
disease_progression 
H-positive risk:  719 709 101 1069 443 105 1030 426 152 54 126 66 
H-negative risk:  709 719 1030 1069 426 443 105 101 126 152 66 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
245 
disease_progression 
H-positive risk:  715 706 100 1079 440 105 1032 419 151 57 129 67 
H-negative risk:  706 715 1032 1079 419 440 105 100 129 151 67 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
246 
disease_progression 
H-positive risk:  714 703 98 1075 451 107 1027 419 152 57 131 66 
H-negative risk:  703 714 1027 1075 419 451 107 98 131 152 66 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
247 
disease_progression 
H-positive risk:  712 703 101 1074 450 107 1031 420 152 55 129 66 
H-negative risk:  703 712 1031 1074 420 450 107 101 129 152 66 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
248 
disease_progression 
H-positive risk:  710 698 99 1076 446 106 1032 428 152 59 129 65 
H-negative risk:  698 710 1032 1076 428 446 106 99 129 152 65 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
249 
disease_progression 
H-positive risk:  703 705 99 1067 450 106 1030 433 154 58 131 64 
H-negative risk:  705 703 1030 1067 433 450 106 99 131 154 64 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
250 
disease_progression 
H-positive risk:  697 707 102 1065 450 107 1028 440 156 56 130 62 
H-negative risk:  707 697 1028 1065 440 450 107 102 130 156 62 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
251 
disease_progression 
H-positive risk:  707 706 101 1067 453 106 1015 442 155 54 132 62 
H-negative risk:  706 707 1015 1067 442 453 106 101 132 155 62 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
252 
disease_progression 
H-positive risk:  712 706 102 1062 454 108 1019 442 155 52 130 58 
H-negative risk:  706 712 1019 1062 442 454 108 102 130 155 58 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
253 
disease_progression 
H-positive risk:  714 710 102 1061 452 107 1018 440 157 50 129 60 
H-negative risk:  710 714 1018 1061 440 452 107 102 129 157 60 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
254 
disease_progression 
H-positive risk:  717 705 102 1055 460 109 1023 430 157 51 131 60 
H-negative risk:  705 717 1023 1055 430 460 109 102 131 157 60 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
255 
disease_progression 
H-positive risk:  715 706 103 1051 457 111 1030 429 157 52 133 56 
H-negative risk:  706 715 1030 1051 429 457 111 103 133 157 56 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
256 
disease_progression 
H-positive risk:  717 695 103 1056 459 111 1031 427 157 51 136 57 
H-negative risk:  695 717 1031 1056 427 459 111 103 136 157 57 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
257 
disease_progression 
H-positive risk:  715 697 104 1058 456 114 1038 412 159 50 141 56 
H-negative risk:  697 715 1038 1058 412 456 114 104 141 159 56 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
258 
disease_progression 
H-positive risk:  712 694 107 1061 464 112 1025 419 160 49 140 57 
H-negative risk:  694 712 1025 1061 419 464 112 107 140 160 57 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
259 
disease_progression 
H-positive risk:  707 695 108 1060 467 110 1028 416 162 51 140 56 
H-negative risk:  695 707 1028 1060 416 467 110 108 140 162 56 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
260 
disease_progression 
H-positive risk:  709 687 107 1067 463 111 1023 420 164 52 140 57 
H-negative risk:  687 709 1023 1067 420 463 111 107 140 164 57 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
261 
disease_progression 
H-positive risk:  714 690 103 1058 467 110 1020 422 161 54 145 56 
H-negative risk:  690 714 1020 1058 422 467 110 103 145 161 56 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
262 
disease_progression 
H-positive risk:  708 693 103 1046 463 111 1031 428 163 53 149 52 
H-negative risk:  693 708 1031 1046 428 463 111 103 149 163 52 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
263 
disease_progression 
H-positive risk:  714 690 101 1049 463 111 1032 421 166 52 149 52 
H-negative risk:  690 714 1032 1049 421 463 111 101 149 166 52 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
264 
disease_progression 
H-positive risk:  721 682 101 1048 463 113 1028 422 166 51 150 55 
H-negative risk:  682 721 1028 1048 422 463 113 101 150 166 55 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
265 
disease_progression 
H-positive risk:  718 682 98 1044 465 112 1034 420 168 50 154 55 
H-negative risk:  682 718 1034 1044 420 465 112 98 154 168 55 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
266 
disease_progression 
H-positive risk:  716 688 99 1045 459 116 1039 414 170 49 151 54 
H-negative risk:  688 716 1039 1045 414 459 116 99 151 170 54 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
267 
disease_progression 
H-positive risk:  715 691 95 1045 461 115 1041 412 171 51 151 52 
H-negative risk:  691 715 1041 1045 412 461 115 95 151 171 52 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
268 
disease_progression 
H-positive risk:  712 685 94 1045 467 116 1043 410 168 54 152 54 
H-negative risk:  685 712 1043 1045 410 467 116 94 152 168 54 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
269 
disease_progression 
H-positive risk:  709 682 96 1042 467 117 1047 411 170 57 152 50 
H-negative risk:  682 709 1047 1042 411 467 117 96 152 170 50 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
270 
disease_progression 
H-positive risk:  706 679 96 1042 477 119 1036 417 168 57 153 50 
H-negative risk:  679 706 1036 1042 417 477 119 96 153 168 50 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
271 
disease_progression 
H-positive risk:  705 674 95 1046 472 118 1038 425 169 57 150 51 
H-negative risk:  674 705 1038 1046 425 472 118 95 150 169 51 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
272 
disease_progression 
H-positive risk:  697 680 94 1058 457 119 1043 426 169 57 152 48 
H-negative risk:  680 697 1043 1058 426 457 119 94 152 169 48 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  705 686 95 1062 456 120 1030 422 166 60 152 46 
H-negative risk:  686 705 1030 1062 422 456 120 95 152 166 46 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
274 
disease_progression 
H-positive risk:  703 684 93 1061 455 123 1038 419 165 59 153 47 
H-negative risk:  684 703 1038 1061 419 455 123 93 153 165 47 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
275 
disease_progression 
H-positive risk:  697 690 93 1063 450 123 1032 424 166 62 152 48 
H-negative risk:  690 697 1032 1063 424 450 123 93 152 166 48 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
276 
disease_progression 
H-positive risk:  694 688 94 1067 447 124 1038 423 163 63 151 48 
H-negative risk:  688 694 1038 1067 423 447 124 94 151 163 48 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
94 new agents 
277 
disease_progression 
H-positive risk:  702 689 94 1069 437 121 1042 424 162 60 152 48 
H-negative risk:  689 702 1042 1069 424 437 121 94 152 162 48 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
278 
disease_progression 
H-positive risk:  696 687 95 1068 435 122 1047 422 166 61 149 52 
H-negative risk:  687 696 1047 1068 422 435 122 95 149 166 52 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
279 
disease_progression 
H-positive risk:  694 683 93 1072 444 120 1048 418 164 62 149 53 
H-negative risk:  683 694 1048 1072 418 444 120 93 149 164 53 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
280 
disease_progression 
H-positive risk:  701 686 94 1068 436 121 1042 419 165 64 152 52 
H-negative risk:  686 701 1042 1068 419 436 121 94 152 165 52 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
281 
disease_progression 
H-positive risk:  703 686 96 1074 433 117 1041 413 167 64 151 55 
H-negative risk:  686 703 1041 1074 413 433 117 96 151 167 55 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
282 
disease_progression 
H-positive risk:  710 675 95 1084 437 117 1039 409 168 64 145 57 
H-negative risk:  675 710 1039 1084 409 437 117 95 145 168 57 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
283 
disease_progression 
H-positive risk:  717 675 95 1090 427 115 1039 407 167 65 148 55 
H-negative risk:  675 717 1039 1090 407 427 115 95 148 167 55 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
96 new agents 
284 
disease_progression 
H-positive risk:  720 668 96 1101 425 114 1039 404 166 66 147 54 
H-negative risk:  668 720 1039 1101 404 425 114 96 147 166 54 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
285 
disease_progression 
H-positive risk:  724 659 96 1103 424 115 1037 406 163 69 146 58 
H-negative risk:  659 724 1037 1103 406 424 115 96 146 163 58 69 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
286 
disease_progression 
H-positive risk:  726 652 97 1111 427 111 1035 400 167 69 147 58 
H-negative risk:  652 726 1035 1111 400 427 111 97 147 167 58 69 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
287 
disease_progression 
H-positive risk:  722 650 96 1128 423 109 1028 404 166 66 149 59 
H-negative risk:  650 722 1028 1128 404 423 109 96 149 166 59 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
288 
disease_progression 
H-positive risk:  722 650 97 1123 411 109 1035 410 167 68 151 57 
H-negative risk:  650 722 1035 1123 410 411 109 97 151 167 57 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
289 
disease_progression 
H-positive risk:  721 648 99 1124 410 109 1030 417 167 69 151 55 
H-negative risk:  648 721 1030 1124 417 410 109 99 151 167 55 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
290 
disease_progression 
H-positive risk:  724 645 101 1130 409 108 1028 412 163 71 154 55 
H-negative risk:  645 724 1028 1130 412 409 108 101 154 163 55 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
291 
disease_progression 
H-positive risk:  725 649 103 1127 409 107 1030 412 159 71 154 54 
H-negative risk:  649 725 1030 1127 412 409 107 103 154 159 54 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
292 
disease_progression 
H-positive risk:  724 650 105 1124 408 110 1035 416 155 67 155 51 
H-negative risk:  650 724 1035 1124 416 408 110 105 155 155 51 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
293 
disease_progression 
H-positive risk:  717 650 105 1122 412 111 1044 410 154 69 157 49 
H-negative risk:  650 717 1044 1122 410 412 111 105 157 154 49 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
294 
disease_progression 
H-positive risk:  720 654 107 1122 416 106 1044 402 153 71 157 48 
H-negative risk:  654 720 1044 1122 402 416 106 107 157 153 48 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
295 
disease_progression 
H-positive risk:  716 660 107 1119 422 104 1041 400 152 72 160 47 
H-negative risk:  660 716 1041 1119 400 422 104 107 160 152 47 72 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
296 
disease_progression 
H-positive risk:  724 669 107 1122 418 105 1030 393 156 73 157 46 
H-negative risk:  669 724 1030 1122 393 418 105 107 157 156 46 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
297 
disease_progression 
H-positive risk:  721 672 110 1118 418 103 1033 390 159 73 156 47 
H-negative risk:  672 721 1033 1118 390 418 103 110 156 159 47 73 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
298 
disease_progression 
H-positive risk:  723 670 108 1124 418 102 1038 381 159 71 159 47 
H-negative risk:  670 723 1038 1124 381 418 102 108 159 159 47 71 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
299 
disease_progression 
H-positive risk:  714 675 108 1120 426 101 1037 381 157 73 161 47 
H-negative risk:  675 714 1037 1120 381 426 101 108 161 157 47 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
300 
disease_progression 
H-positive risk:  708 676 105 1119 424 100 1043 378 159 75 164 49 
H-negative risk:  676 708 1043 1119 378 424 100 105 164 159 49 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
301 
disease_progression 
H-positive risk:  710 677 105 1116 420 99 1048 377 156 75 165 52 
H-negative risk:  677 710 1048 1116 377 420 99 105 165 156 52 75 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
302 
disease_progression 
H-positive risk:  720 678 107 1111 418 101 1045 371 155 76 166 52 
H-negative risk:  678 720 1045 1111 371 418 101 107 166 155 52 76 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
303 
disease_progression 
H-positive risk:  713 681 106 1111 427 98 1049 372 154 77 158 54 
H-negative risk:  681 713 1049 1111 372 427 98 106 158 154 54 77 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
304 
disease_progression 
H-positive risk:  704 678 103 1108 430 99 1056 380 153 78 158 53 
H-negative risk:  678 704 1056 1108 380 430 99 103 158 153 53 78 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
305 
disease_progression 
H-positive risk:  691 680 102 1111 434 98 1061 378 156 77 154 58 
H-negative risk:  680 691 1061 1111 378 434 98 102 154 156 58 77 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
306 
disease_progression 
H-positive risk:  687 685 101 1113 436 97 1063 377 155 74 153 59 
H-negative risk:  685 687 1063 1113 377 436 97 101 153 155 59 74 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
94 new agents 
307 
disease_progression 
H-positive risk:  694 685 101 1110 438 98 1054 377 152 73 158 60 
H-negative risk:  685 694 1054 1110 377 438 98 101 158 152 60 73 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
308 
disease_progression 
H-positive risk:  697 694 100 1116 441 95 1042 375 153 74 158 55 
H-negative risk:  694 697 1042 1116 375 441 95 100 158 153 55 74 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
309 
disease_progression 
H-positive risk:  699 705 101 1115 437 95 1038 373 151 72 159 55 
H-negative risk:  705 699 1038 1115 373 437 95 101 159 151 55 72 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
310 
disease_progression 
H-positive risk:  694 705 102 1108 436 96 1043 375 152 72 161 56 
H-negative risk:  705 694 1043 1108 375 436 96 102 161 152 56 72 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
311 
disease_progression 
H-positive risk:  688 700 101 1098 447 97 1060 371 154 70 161 53 
H-negative risk:  700 688 1060 1098 371 447 97 101 161 154 53 70 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
312 
disease_progression 
H-positive risk:  690 697 102 1095 446 93 1063 375 156 68 162 53 
H-negative risk:  697 690 1063 1095 375 446 93 102 162 156 53 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
313 
disease_progression 
H-positive risk:  689 694 99 1102 446 92 1065 374 152 69 166 52 
H-negative risk:  694 689 1065 1102 374 446 92 99 166 152 52 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
314 
disease_progression 
H-positive risk:  686 691 97 1106 449 91 1072 368 152 70 168 50 
H-negative risk:  691 686 1072 1106 368 449 91 97 168 152 50 70 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
315 
disease_progression 
H-positive risk:  690 687 97 1107 454 92 1066 369 152 69 170 47 
H-negative risk:  687 690 1066 1107 369 454 92 97 170 152 47 69 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
316 
disease_progression 
H-positive risk:  691 683 100 1108 447 92 1068 373 157 67 165 49 
H-negative risk:  683 691 1068 1108 373 447 92 100 165 157 49 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
317 
disease_progression 
H-positive risk:  690 689 102 1109 441 93 1066 374 159 65 163 49 
H-negative risk:  689 690 1066 1109 374 441 93 102 163 159 49 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
318 
disease_progression 
H-positive risk:  695 686 100 1115 437 91 1067 376 160 60 167 46 
H-negative risk:  686 695 1067 1115 376 437 91 100 167 160 46 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
319 
disease_progression 
H-positive risk:  693 688 102 1115 431 91 1071 372 162 60 168 47 
H-negative risk:  688 693 1071 1115 372 431 91 102 168 162 47 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
320 
disease_progression 
H-positive risk:  689 689 99 1115 433 91 1075 368 164 56 173 48 
H-negative risk:  689 689 1075 1115 368 433 91 99 173 164 48 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
321 
disease_progression 
H-positive risk:  687 676 96 1116 433 92 1076 375 167 56 177 49 
H-negative risk:  676 687 1076 1116 375 433 92 96 177 167 49 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
322 
disease_progression 
H-positive risk:  682 675 95 1116 442 91 1072 371 168 61 178 49 
H-negative risk:  675 682 1072 1116 371 442 91 95 178 168 49 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
323 
disease_progression 
H-positive risk:  691 679 94 1111 443 93 1066 368 167 61 180 47 
H-negative risk:  679 691 1066 1111 368 443 93 94 180 167 47 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
324 
disease_progression 
H-positive risk:  695 680 94 1105 446 93 1057 369 169 62 180 50 
H-negative risk:  680 695 1057 1105 369 446 93 94 180 169 50 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
325 
disease_progression 
H-positive risk:  693 677 94 1109 445 92 1060 373 166 65 178 48 
H-negative risk:  677 693 1060 1109 373 445 92 94 178 166 48 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
326 
disease_progression 
H-positive risk:  680 676 92 1112 437 92 1071 383 167 62 181 47 
H-negative risk:  676 680 1071 1112 383 437 92 92 181 167 47 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
327 
disease_progression 
H-positive risk:  678 675 93 1117 443 90 1066 381 167 61 181 48 
H-negative risk:  675 678 1066 1117 381 443 90 93 181 167 48 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
328 
disease_progression 
H-positive risk:  679 670 94 1125 436 90 1068 381 169 57 178 53 
H-negative risk:  670 679 1068 1125 381 436 90 94 178 169 53 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
329 
disease_progression 
H-positive risk:  684 666 92 1119 436 88 1072 378 168 59 182 56 
H-negative risk:  666 684 1072 1119 378 436 88 92 182 168 56 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
330 
disease_progression 
H-positive risk:  688 666 96 1116 443 89 1063 378 164 60 181 56 
H-negative risk:  666 688 1063 1116 378 443 89 96 181 164 56 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
331 
disease_progression 
H-positive risk:  689 670 95 1118 437 89 1066 377 169 55 179 56 
H-negative risk:  670 689 1066 1118 377 437 89 95 179 169 56 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
332 
disease_progression 
H-positive risk:  691 665 96 1115 442 89 1061 383 165 57 179 57 
H-negative risk:  665 691 1061 1115 383 442 89 96 179 165 57 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
333 
disease_progression 
H-positive risk:  691 662 95 1107 442 89 1069 379 168 56 181 61 
H-negative risk:  662 691 1069 1107 379 442 89 95 181 168 61 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
334 
disease_progression 
H-positive risk:  699 666 93 1108 432 86 1067 384 172 54 176 63 
H-negative risk:  666 699 1067 1108 384 432 86 93 176 172 63 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
335 
disease_progression 
H-positive risk:  703 659 92 1119 426 84 1068 384 176 50 174 65 
H-negative risk:  659 703 1068 1119 384 426 84 92 174 176 65 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
336 
disease_progression 
H-positive risk:  690 655 94 1119 431 84 1070 385 179 52 178 63 
H-negative risk:  655 690 1070 1119 385 431 84 94 178 179 63 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
337 
disease_progression 
H-positive risk:  682 653 95 1119 438 85 1064 394 174 54 177 65 
H-negative risk:  653 682 1064 1119 394 438 85 95 177 174 65 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
338 
disease_progression 
H-positive risk:  685 647 97 1123 440 85 1055 397 173 55 177 66 
H-negative risk:  647 685 1055 1123 397 440 85 97 177 173 66 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
59 new agents 
339 
disease_progression 
H-positive risk:  689 643 99 1124 442 85 1049 395 173 57 178 66 
H-negative risk:  643 689 1049 1124 395 442 85 99 178 173 66 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
340 
disease_progression 
H-positive risk:  689 647 99 1124 446 83 1047 387 173 58 181 66 
H-negative risk:  647 689 1047 1124 387 446 83 99 181 173 66 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  690 643 97 1125 446 84 1045 391 171 58 183 67 
H-negative risk:  643 690 1045 1125 391 446 84 97 183 171 67 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 64 34 

clinical_engagement 
diagnosis 
demography 
90 new agents 
342 
disease_progression 
H-positive risk:  684 645 95 1127 448 83 1051 391 174 58 179 65 
H-negative risk:  645 684 1051 1127 391 448 83 95 179 174 65 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 68 34 

clinical_engagement 
diagnosis 
demography 
95 new agents 
343 
disease_progression 
H-positive risk:  686 640 96 1131 444 87 1052 390 169 56 178 71 
H-negative risk:  640 686 1052 1131 390 444 87 96 178 169 71 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 69 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
344 
disease_progression 
H-positive risk:  678 640 98 1139 444 88 1051 390 167 56 177 72 
H-negative risk:  640 678 1051 1139 390 444 88 98 177 167 72 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 70 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
345 
disease_progression 
H-positive risk:  680 638 97 1147 431 87 1057 389 167 57 177 73 
H-negative risk:  638 680 1057 1147 389 431 87 97 177 167 73 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
93 new agents 
346 
disease_progression 
H-positive risk:  686 642 99 1145 420 90 1057 388 166 57 179 71 
H-negative risk:  642 686 1057 1145 388 420 90 99 179 166 71 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 72 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
347 
disease_progression 
H-positive risk:  689 647 100 1142 412 92 1059 389 163 57 178 72 
H-negative risk:  647 689 1059 1142 389 412 92 100 178 163 72 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 71 36 

clinical_engagement 
diagnosis 
demography 
85 new agents 
348 
disease_progression 
H-positive risk:  687 653 100 1150 414 92 1056 379 162 55 181 71 
H-negative risk:  653 687 1056 1150 379 414 92 100 181 162 71 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
349 
disease_progression 
H-positive risk:  690 650 102 1143 420 92 1050 383 163 54 179 74 
H-negative risk:  650 690 1050 1143 383 420 92 102 179 163 74 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 63 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
350 
disease_progression 
H-positive risk:  691 650 104 1140 420 89 1043 392 162 57 180 72 
H-negative risk:  650 691 1043 1140 392 420 89 104 180 162 72 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 64 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
351 
disease_progression 
H-positive risk:  697 651 104 1135 430 91 1040 385 158 56 179 74 
H-negative risk:  651 697 1040 1135 385 430 91 104 179 158 74 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 62 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
352 
disease_progression 
H-positive risk:  699 646 105 1144 424 90 1041 392 158 53 176 72 
H-negative risk:  646 699 1041 1144 392 424 90 105 176 158 72 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
91 new agents 
353 
disease_progression 
H-positive risk:  705 644 105 1149 427 91 1041 383 155 51 175 74 
H-negative risk:  644 705 1041 1149 383 427 91 105 175 155 74 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
354 
disease_progression 
H-positive risk:  695 652 103 1151 424 90 1052 379 158 49 175 72 
H-negative risk:  652 695 1052 1151 379 424 90 103 175 158 72 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 60 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
355 
disease_progression 
H-positive risk:  686 658 103 1147 424 88 1049 387 159 53 176 70 
H-negative risk:  658 686 1049 1147 387 424 88 103 176 159 70 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 60 34 

clinical_engagement 
diagnosis 
demography 
86 new agents 
356 
disease_progression 
H-positive risk:  683 660 101 1147 432 90 1056 378 158 52 178 65 
H-negative risk:  660 683 1056 1147 378 432 90 101 178 158 65 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 59 33 

clinical_engagement 
diagnosis 
demography 
94 new agents 
357 
disease_progression 
H-positive risk:  688 658 107 1142 426 92 1051 383 160 54 174 65 
H-negative risk:  658 688 1051 1142 383 426 92 107 174 160 65 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 59 34 

clinical_engagement 
diagnosis 
demography 
87 new agents 
358 
disease_progression 
H-positive risk:  693 664 111 1142 410 89 1053 385 158 55 177 63 
H-negative risk:  664 693 1053 1142 385 410 89 111 177 158 63 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 59 34 

clinical_engagement 
diagnosis 
demography 
86 new agents 
359 
disease_progression 
H-positive risk:  694 670 108 1136 408 92 1053 392 155 55 176 61 
H-negative risk:  670 694 1053 1136 392 408 92 108 176 155 61 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 55 37 

clinical_engagement 
diagnosis 
demography 
68 new agents 
360 
disease_progression 
H-positive risk:  694 662 106 1145 409 90 1048 398 154 57 179 58 
H-negative risk:  662 694 1048 1145 398 409 90 106 179 154 58 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 52 39 

clinical_engagement 
diagnosis 
demography 
75 new agents 
Time difference of 17.18665 mins
This is task 6
